The importance of bone health
management in prostate cancer patients
Livestream: 25 January 2021, 18:00 – 20:00 CET
For healthcare professionals only*
This website is intended for healthcare professionals.


Remember to check the box

*Healthcare Professional (HCP): A member of the medical, dental, pharmacy or nursing professions or any other person who, in the course of his/her professional activities, may prescribe, purchase, supply, recommend or administer a medicinal product and whose primary practice, principal professional address or place of incorporation is in Europe.
Disclaimer
Please note that this event is intended for healthcare professionals (HCPs) only and must be viewed in a location where the content is not visible or audible to non-HCPs. Please take care to launch this event in an appropriate location. We call attention to the fact that you agreed to these terms when you registered for this event. If you can no longer abide by these terms, please do not proceed to the event.

This is an event initiated by Astellas.
Astellas Pharma (Astellas) will be conducting filming, photography, audio recording and other media recording of the webinar and discussions as part of this event. The recording activities may entail capturing personal information about yourself, including your name, image, job title, voice, appearance and any information you disclose if you speak publicly at the event.
Astellas Pharma is committed to protecting your personal information and will only use it in accordance with the applicable data privacy law and our Astellas Privacy Notice.
For further information on how we process and protect your personal information and how you may exercise your data protection rights, please refer to our Astellas Privacy Notice at policy.astellas.dk/en-general-privacy-notice/

For your information: Astellas Pharma has a legal obligation to report adverse events for Astellas products, if these are mentioned during the course of the webinar.

Important information for Norwegian participants
For deltagere med arbeidssted i Norge: Ved å melde deg på dette arrangementet bekrefter du at møtet er godkjent av din arbeidsgiver og at reglene som gjelder din arbeidsplass er fulgt.

Important information for Swedish participants
Denna inbjudan har skickats till onkologer, urologer och endokrinologer, med kopia till verksamhetschefer och berörda läkemedelskommittéer. I enlighet med gällande avtal mellan LIF (Läkemedelsindustriföreningen) och SKR (Sveriges Kommuner och Regioner) vill vi göra dig uppmärksam på att ditt deltagande ska vara godkänt av din verksamhetschef. Information om Överenskommelse om Samverkansregler mellan läkemedelsföretag och medarbetare i den offentligt finansierade hälso- och sjukvården finns på www.lif.se.

Important information for Danish participants
  • Tilmelding, kan ske efter den gældende regionsaftale
  • Tilmelding er betinget af, at ledelsen har truffet beslutning om deltagelse, herunder hvilke medarbejdere der deltager i aktiviteten
  • Arrangementet fører ikke andre forpligtelser med sig, end deltagelse i selve arrangementet.
Cookies are used on this website. By continuing, you automatically accept cookies. If you do not wish to accept cookies, please click here to find out how to manage cookies.

Astellas Pharma a/s
Kajakvej 2
2770 Kastrup, Denmark
Telefon 4343 0355
kontakt.dk@astellas.com
www.astellas.dk
Astellas Pharma
Vaisalantie 2–8
02130 Espoo, Finland
Puhelin 09 8560 6000
info.fi@astellas.com
www.astellas.com
Astellas Pharma
Hagaløkkveien 26
1385 Asker, Norway
Telefon 66 76 46 00
kontakt.no@astellas.com
www.astellas.no
Astellas Pharma AB
Box 21046
200 21 Malmö, Sweden
Telefon 040-650 15 00
info.se@astellas.com
www.astellas.se
ONC_2020_0053_NC 12.2020
Footer information
Regular footer information goes here